Background Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …

Background Pancreatic cancer is an insidious and heterogeneous malignancy with poor
prognosis that is often locally unresectable. Therefore, determining the underlying …

Substantial alterations at the multi-omics level of pancreatic cancer (PC) impede the
possibility to diagnose and treat patients in early stages. Herein, we conducted an …

Pancreatic cancer (PC) is one of the leading causes of cancer-related death globally. So,
identification of potential molecular signatures is required for diagnosis, prognosis, and …

Pancreatic cancer (PC) is one of the most common causes of cancer mortality worldwide. As
the genetic mechanism of this complex disease is not uncovered clearly, identification of …

Pancreatic adenocarcinoma (PAAD) is a type of malignant tumor with the highest mortality
rate among all neoplasms worldwide, and its exact pathogenesis is still poorly understood …

Background Pancreatic adenocarcinoma is one of the highly invasive and the seventh most
common cause of death among cancers worldwide. To identify key genes and the involved …

Pancreatic cancer is a highly malignant neoplastic disease of the digestive system. In the
present study, the dataset GSE62165 was downloaded from the Gene Expression Omnibus …

Background Pancreatic carcinoma (PC) is one of the most aggressive cancers affecting
human health. It is essential to identify candidate biomarkers for the diagnosis and …

Pancreatic adenocarcinoma (PAAD) is a malignant tumor of the digestive system, which
develops rapidly and has no obvious early symptoms. This study aims to discover the …